https://finance.yahoo.com/news/cidaras-lower-expected-q4-earnings-163533964.html
0
0
3/23/23 at 4:35pm
Organization
Yahoo Entertainment
Author
Vandana Singh
The FDA approved Cidara Therapeutics Inc's (NASDAQ: CDTX) antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive...
Create an account
or login to join the discussion